Simani, L., Tozlu, C., Lee, S., Dworkin, J., Ratzan, A. S., Buyukturkoglu, K., Onomichi, K., Mata, J., Riley, C. S., & Leavitt, V. M. (2025). Longitudinal investigation of neuroimaging changes related to memory decline in multiple sclerosis: Testing a mechanistic model. Multiple Sclerosis Journal, 31(2), 207–217. https://doi.org/10.1177/13524585241303491

Kever, A., Heuer, L. B., Simani, L., & Leavitt, V. M. (2024). Development and initial validation of the Cognitive Change Scale (CCS). Multiple Sclerosis Journal, 30(14), 1815–1824. https://doi.org/10.1177/13524585241290102

Holtzer, R., Foley, F. W., Motl, R. W., Wagshul, M. E., Hernandez, M. E., Lipton, M. L., Picone, M. A., & Izzetoglu, M. (2024). Brain hemodynamic responses and fall prediction in older adults with multiple sclerosis. Multiple Sclerosis Journal, 30(13), 1664–1673. https://doi.org/10.1177/13524585241277400

Koch, M. W., Camara-Lemarroy, C., Strijbis, E., Mostert, J., Leavitt, V. M., Repovic, P., Bowen, J. D., Comtois, J., Uitdehaag, B., & Cutter, G. (2024). Selecting informative patients for phase 2 progressive trials in MS: Design considerations for phase 2 clinical trials in progressive MS. Multiple Sclerosis Journal. https://doi.org/10.1177/13524585241274620

Bebo, B. F., Banwell, B. L., Whitacre, C. C., Coetzee, T., Dalgas, U., De Jager, P. L., Proebstel, A.-K., Yong, V. W., Benveniste, E. N., & Thompson, A. J. (2024). The refined Pathways to Cures Research Roadmap for multiple sclerosis cures. Multiple Sclerosis Journal, 30(10), 1242–1251. https://doi.org/10.1177/13524585241266483

Leavitt, V. M. (2024). Depression is a core symptom of multiple sclerosis: No. Multiple Sclerosis Journal, 30(7), 787–788. https://doi.org/10.1177/13524585241245653

Anderson, J. R., Fitzgerald, K. C., Murrough, J. W., Katz Sand, I. B., Sorets, T. R., Krieger, S. C., Riley, C. S., Fabian, M. T., & Sumowski, J. F. (2023). Depression symptoms and cognition in multiple sclerosis: Longitudinal evidence of a specific link to executive control. Multiple Sclerosis Journal, 29(13), 1632–1645. https://doi.org/10.1177/13524585231198746

Cote, S. E., Wagshul, M. E., Foley, F. W., Lipton, M. L., & Holtzer, R. (2023). Caudate volume and symptoms of apathy in older adults with multiple sclerosis. Multiple Sclerosis Journal, 29(10), 1266–1274. https://doi.org/10.1177/13524585231188096

Klineova, S., Farber, R. S., DeAngelis, T., Leung, T., Smith, T., Blanck, R., Zhovtis-Ryerson, L., & Harel, A. (2023). Vaccine-breakthrough SARS-CoV-2 infections in people with multiple sclerosis and related conditions: An observational study by the New York COVID-19 Neuro-Immunology Consortium (NYCNIC-2). Multiple Sclerosis Journal, 29(8), 990–1000. https://doi.org/10.1177/13524585231185246

Wilkins, S. R., Yu, A. W., Steigerwald, C., Tanji, K., Iglesias, A. D., Hirano, M., Kister, I., Riley, C. S., & Abreu, N. J. (2023). Two cases of MT-ND5-related mitochondrial disorder misdiagnosed as seronegative neuromyelitis optica spectrum disorder. Multiple Sclerosis Journal, 29(7), 892–897. https://doi.org/10.1177/13524585231172947

Leavitt, V. M., Dworkin, J. D., Buyukturkoglu, K., Riley, C. S., & Ritchey, M. (2022). Summary metrics of memory subnetwork functional connectivity alterations in multiple sclerosis. Multiple Sclerosis Journal, 28(12), 1963–1972. https://doi.org/10.1177/13524585221099169

Kever, A., Riley, C. S., & Leavitt, V. M. (2022). Diagnosis concealment is associated with psychosocial outcomes in persons with multiple sclerosis. Multiple Sclerosis Journal, 28(8), 1311–1314. https://doi.org/10.1177/13524585211070496

Kever, A., & Leavitt, V. M. (2021). Assessing diagnosis disclosure and concealment in multiple sclerosis: Development and initial validation of the DISCO-MS survey. Multiple Sclerosis Journal, 28(2), 247–256. https://doi.org/10.1177/13524585211037581

Kever, A., Buyukturkoglu, K., Levin, S. N., Riley, C. S., De Jager, P., & Leavitt, V. M. (2021). Associations of social network structure with cognition and amygdala volume in multiple sclerosis: An exploratory investigation. Multiple Sclerosis Journal, 28(2), 228–236. https://doi.org/10.1177/13524585211018349